No. 18A980

Pfizer Inc. v. Alida Adamyan, et al.

Lower Court: Ninth Circuit
Docketed: 2019-03-28
Status: Presumed Complete
Type: A
Experienced Counsel
Tags: CAFA class-action-fairness-act federal-question-jurisdiction joint-trial mass-action-removal products-liability
Key Terms:
Jurisdiction ClassAction JusticiabilityDoctri
Latest Conference: N/A
Question Presented (from Petition)

Whether a state court's sua sponte proposal that claims brought by thousands of plaintiffs from around the country be "tried jointly" qualifies for "mass action" removal under the Class Action Fairness Act, 28 U.S.C. § 1332(d)(11).

Question Presented (AI Summary)

Whether a state court's sua sponte proposal to try claims jointly constitutes a 'mass action' removable under the Class Action Fairness Act when the proposal is made by judicial order rather than by the plaintiffs themselves

Docket Entries

2019-03-28
Application (18A980) granted by Justice Kagan extending the time to file until June 21, 2019.
2019-03-25
Application (18A980) to extend the time to file a petition for a writ of certiorari from April 22, 2019 to June 21, 2019, submitted to Justice Kagan.

Attorneys

Pfizer, Inc.
Michael Hugh McGinleyDechert LLP, Petitioner